Reducing inflammation ‘could ease dying’

For the first time in cancer research, scientists have discovered that controlling patients’ inflammatory process will help control the level of pain, fatigue, loss of appetite and nausea experienced in their last weeks of life.

Until now it was thought that these symptoms were an inevitable side effect of advanced cancer and that there was little doctors could do to help alleviate these symptoms. This study however, shows that the symptoms experienced by people at the end of their life is actually due to the body’s inflammatory response to the cancer and that controlling this response could therefore help control the symptoms.

The study was lead by Dr Barry Laird at Edinburgh University and was a joint venture with the European Palliative Care Research Centre. It used blood tests from over 2,500 patients to assess inflammation levels in patients with various cancers including breast, lung and colon cancer and found that a person's level of inflammation appeared to have a direct effect on the way they felt.

Dr Laird said "We already have drugs that target and reduce inflammation, so using these drugs specifically to treat symptoms may make a real difference to people living with cancer."

Read More


Comments are closed.